Sarat Investments Holdings
Privately owned Riyadh-based investment holding company active in real estate, environmental health, hospitality, entertainment and health services. In 2026 it announced an advisory collaboration with ARC Advisory and a USD 100 million life sciences fund.
Industry: Investment holding | Location: Riyadh, Saudi Arabia
About Sarat Investments Holdings
Sarat Investments Holdings is a privately owned Saudi Arabian investment company headquartered in Riyadh. According to its website, it forms joint ventures and partnerships with international companies to invest in and develop businesses in sectors of Saudi Arabia that it describes as underserved, and it links its goals to Saudi Vision 2030.
The website lists six areas of activity. Real estate covers residential and commercial developments. Environmental health covers biofuels, waste management and clean energy, with OMPECO linked as the related business. Hospitality covers bringing luxury hospitality brands to the Middle East, with Yakoon linked. In entertainment, the site says Sarat holds a major shareholding in global entertainment companies and names Le Seize as its entertainment business unit. Health services and solutions covers distributing digital pathology and wellness products in partnership with Advanced Health Solutions. The sixth area is charity, described as corporate social responsibility work. The site does not state a founding date or list management.
In April 2026 Kuwait Times and GCC Business News reported a collaboration between Sarat and ARC Advisory, the advisory arm of Kuwait-based OJO Group, supporting ARC's expansion into Saudi Arabia. GCC Business News reported that Sarat manages more than USD 20 billion in assets and that USD 350 million of live projects are expected to conclude by the end of 2026.
Sarat is also linked to biotechnology investing. Private Equity International lists a September 2025 commitment by Sarat to the Sarat Ventures Y Innovations Biotech Fund (UK), announced on 10 September 2025 with an expected size of about USD 50 million and Allocator One as anchor. Companies House shows the fund's limited partnership as registered on 11 September 2025. In September 2026 Enterprise reported that Sarat Investments Holding had launched a USD 100 million life sciences fund with a five-year term, aimed at 15 to 20 startups at Series A or later with annual revenues of up to about USD 2 million.